Zion projects patient controlled analgesia pumps market to reach $3.83 billion by 2034

The research firm said the market was valued at $656.26 million in 2024 and forecasts 19.30% CAGR, with North America leading and electronic, intravenous and hospital segments dominant.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.